{"id":6947,"date":"2021-07-28T10:12:56","date_gmt":"2021-07-28T08:12:56","guid":{"rendered":"https:\/\/filinf.it\/?page_id=6947"},"modified":"2024-02-23T16:49:18","modified_gmt":"2024-02-23T15:49:18","slug":"aggressive-lymphomas","status":"publish","type":"page","link":"https:\/\/filinf.it\/en\/structure\/scientific-commission\/aggressive-lymphomas\/","title":{"rendered":"Aggressive Lymphomas Commission"},"content":{"rendered":"<p><span data-contrast=\"auto\">The <strong>aggressive lymphomas<\/strong> are a group of diseases that affect the\u00a0<\/span><b><span data-contrast=\"auto\">lymphatic system<\/span><\/b><span data-contrast=\"auto\">, or rather cells and tissues that are responsible for defending the body against external agents and disease and to ensure proper circulation of fluids in the body. The aggressive lymphomas include <a href=\"https:\/\/filinf.it\/en\/about-limphomas\/non-hodgkin-lymphomas-nhl\/\">non-Hodgkin lymphomas<\/a> that can develop into different organs (lymph nodes, but also the stomach, intestine, skin and central nervous system) from\u00a0<\/span><b><span data-contrast=\"auto\">B lymphocytes<\/span><\/b><span data-contrast=\"auto\">\u00a0and\u00a0<\/span><b><span data-contrast=\"auto\">T lymphocytes<\/span><\/b><span data-contrast=\"auto\">\u00a0(T lymphomas treated by the <a href=\"https:\/\/filinf.it\/en\/structure\/scientific-commission\/t-lymphomas\/\">T lymphomas Commission<\/a>).<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:200,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">The <strong>aggressive lymphomas<\/strong> can develop in any part of the body. The most frequent localizations are found in the lymph nodes of the neck, armpit, diaphragm, inguinal, abdominal and in different organs.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:200,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone\" title=\"Linfomi Aggressivi\" src=\"https:\/\/filinf.it\/wp-content\/uploads\/2009\/12\/Linfociti-B-sani-1024x768.jpg\" alt=\"Linfomi Aggressivi\" width=\"640\" height=\"480\" \/><\/p>\n<p><span data-contrast=\"auto\">The <strong>Aggressive Lymphomas Commission<\/strong> deals with\u00a0<\/span><b><span data-contrast=\"auto\">studies<\/span><\/b><span data-contrast=\"auto\">\u00a0involving:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:200,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Diffuse large B-cell lymphomas (DLBCL);\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Mantle Cell lymphomas (MCL);\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Burkitt lymphoma;\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Primary Mediastinal large B-cell lymphomas (PMLBCL).\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">The\u00a0<\/span><b><span data-contrast=\"auto\">goals\u00a0<\/span><\/b><span data-contrast=\"auto\">of <strong>Aggressive Lymphomas Commission<\/strong> are:<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<ol>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, Calibri_MSFontService, sans-serif\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Approve the proposals for Phase III national and international studies, aimed at comparing standard therapy with therapeutic strategies in aggressive lymphomas listed above;\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, Calibri_MSFontService, sans-serif\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Approve the proposals for Phase II trials with drugs or combinations of innovative drugs, in groups of patients selected for age or for specific clinical features;\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, Calibri_MSFontService, sans-serif\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Cooperate with the Commission for Biological Studies conducting integrated analysis on the clinical prognosis of biological parameters, such as minimal residual disease;\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, Calibri_MSFontService, sans-serif\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Cooperate with the Commission Imaging and Radioimmunotherapy and Commission Radiotherapy for prospective analysis on the prognostic significance of imaging techniques such as PET and analysis regarding radiotherapy;\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, Calibri_MSFontService, sans-serif\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Participate and collaborate with the International Cooperative groups in prospective clinical trials;\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, Calibri_MSFontService, sans-serif\" data-listid=\"1\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Carry out scientific advice for prospective studies sponsored by international companies in aggressive lymphomas.<\/span><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>The aggressive lymphomas are a group of diseases that affect the\u00a0lymphatic system, or rather cells and tissues that are responsible&#8230;<\/p>\n","protected":false},"author":10003,"featured_media":0,"parent":6944,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/filinf.it\/en\/wp-json\/wp\/v2\/pages\/6947"}],"collection":[{"href":"https:\/\/filinf.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/filinf.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/filinf.it\/en\/wp-json\/wp\/v2\/users\/10003"}],"replies":[{"embeddable":true,"href":"https:\/\/filinf.it\/en\/wp-json\/wp\/v2\/comments?post=6947"}],"version-history":[{"count":0,"href":"https:\/\/filinf.it\/en\/wp-json\/wp\/v2\/pages\/6947\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/filinf.it\/en\/wp-json\/wp\/v2\/pages\/6944"}],"wp:attachment":[{"href":"https:\/\/filinf.it\/en\/wp-json\/wp\/v2\/media?parent=6947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}